Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
CERE
Fundamentals

Cerevel Therapeutics Holdings, Inc.

CERE

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
12 Months Change

Assets

1.13B
▼-115.96M▼-9.33%
3 Months Change

Liabilities

562.89M
▼-6.67M▼-1.17%
3 Months Change

Free Cash Flow

-119.94M
▼-24.68M▼-25.91%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-05-08
Form 10-Q
ID: 0000950170-24-055701
2024-02-16
Form 8-K
ID: 0001193125-24-038534
2023-12-07
Form 8-K
ID: 0001193125-23-290340
2023-11-01
Form 10-Q
ID: 0000950170-23-057422
2023-11-01
Form 8-K
ID: 0000950170-23-057107
2023-10-12
Form 8-K
ID: 0001193125-23-255026
2023-10-11
Form 8-K
ID: 0001193125-23-254146
2023-08-02
Form 10-Q
ID: 0000950170-23-037151
2023-08-02
Form 8-K
ID: 0000950170-23-036758
2023-06-08
Form 8-K
ID: 0001193125-23-163542